delek us holdings inc. - DK
DK
Close Chg Chg %
18.04 0.35 1.94%
Closed Market
18.39
+0.35 (1.94%)
Volume: 641.56K
Last Updated:
Nov 21, 2024, 3:59 PM EDT
Company Overview: delek us holdings inc. - DK
DK Key Data
Open $18.32 | Day Range 17.97 - 18.67 |
52 Week Range 15.36 - 33.59 | Market Cap $1.14B |
Shares Outstanding 63.20M | Public Float 61.58M |
Beta 1.14 | Rev. Per Employee N/A |
P/E Ratio N/A | EPS -$6.40 |
Yield 548.78% | Dividend $0.26 |
EX-DIVIDEND DATE Nov 12, 2024 | SHORT INTEREST N/A |
AVERAGE VOLUME 1.25M |
DK Performance
1 Week | -1.39% | ||
1 Month | 8.11% | ||
3 Months | -11.63% | ||
1 Year | -32.74% | ||
5 Years | -48.26% |
DK Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
14
Full Ratings ➔
About delek us holdings inc. - DK
Delek US Holdings, Inc. engages in petroleum refining, and the transportation, storage, and wholesale distribution of crude oil. It operates through the following segments: Refining, Logistics, Retail, and Corporate and Other. The Refining segment processes crude oil and other purchased feedstocks for the manufacture of transportation motor fuels, including gasoline, diesel fuel and aviation fuel, asphalt, and other petroleum-based products. The Logistics segment gathers, transports, and stores crude oil and markets, distributes, transports, and stores refined products. The Retail segment markets gasoline, diesel and other refined petroleum products, and convenience merchandise through a network of company-operated retail fuel and convenience stores. The company was founded in 2001 and is headquartered in Brentwood, TN.
DK At a Glance
Delek US Holdings, Inc.
310 Seven Springs Way
Brentwood, Tennessee 37027
Phone | 1-615-771-6701 | Revenue | 16.92B | |
Industry | Oil Refining/Marketing | Net Income | 19.80M | |
Sector | Energy Minerals | Employees | 3,591 | |
Fiscal Year-end | 12 / 2024 | |||
View SEC Filings |
DK Valuation
P/E Current | N/A |
P/E Ratio (with extraordinary items) | N/A |
P/E Ratio (without extraordinary items) | 85.971 |
Price to Sales Ratio | 0.101 |
Price to Book Ratio | 1.952 |
Price to Cash Flow Ratio | 1.655 |
Enterprise Value to EBITDA | 5.118 |
Enterprise Value to Sales | 0.222 |
Total Debt to Enterprise Value | 0.736 |
DK Efficiency
Revenue/Employee | 4,711,055.416 |
Income Per Employee | 5,513.784 |
Receivables Turnover | 21.168 |
Total Asset Turnover | 2.202 |
DK Liquidity
Current Ratio | 0.993 |
Quick Ratio | 0.627 |
Cash Ratio | 0.306 |
DK Profitability
Gross Margin | 3.887 |
Operating Margin | 2.264 |
Pretax Margin | 0.306 |
Net Margin | 0.117 |
Return on Assets | 0.258 |
Return on Equity | 2.213 |
Return on Total Capital | 0.548 |
Return on Invested Capital | 0.524 |
DK Capital Structure
Total Debt to Total Equity | 327.108 |
Total Debt to Total Capital | 76.587 |
Total Debt to Total Assets | 38.564 |
Long-Term Debt to Equity | 315.376 |
Long-Term Debt to Total Capital | 73.84 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Delek Us Holdings Inc. - DK
Collapse All in section
All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
---|---|---|---|---|---|
Sales/Revenue
| 7.30B | 10.65B | 20.25B | 16.92B | |
Sales Growth
| -21.47% | +45.83% | +90.13% | -16.44% | |
Cost of Goods Sold (COGS) incl D&A
| 7.59B | 10.64B | 19.41B | 16.26B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 338.10M | 325.20M | 349.60M | 351.60M | |
Depreciation
| 330.50M | 317.80M | 334.60M | 326.60M | |
Amortization of Intangibles
| 7.60M | 7.40M | 15.00M | 25.00M | |
COGS Growth
| -11.35% | +40.24% | +82.49% | -16.24% | |
Gross Income
| (283.40M) | 10.50M | 832.60M | 657.60M | |
Gross Income Growth
| -138.21% | +103.71% | +7,829.52% | -21.02% | |
Gross Profit Margin
| -3.88% | +0.10% | +4.11% | +3.89% |
2020 | 2021 | 2022 | 2023 | 5-year trend | |
---|---|---|---|---|---|
SG&A Expense
| 248.30M | 225.40M | 348.80M | 272.90M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 248.30M | 225.40M | 348.80M | 272.90M | |
SGA Growth
| -9.21% | -9.22% | +54.75% | -21.76% | |
Other Operating Expense
| (8.60M) | (24.60M) | (1.80M) | 1.70M | |
Unusual Expense
| 206.40M | (49.90M) | 25.70M | 109.50M | |
EBIT after Unusual Expense
| (729.50M) | (140.40M) | 459.90M | 273.50M | |
Non Operating Income/Expense
| 95.40M | 44.60M | 89.80M | 96.50M | |
Non-Operating Interest Income
| - | - | 3.30M | 500.00K | - |
Equity in Earnings of Affiliates
| 30.30M | 18.30M | 57.70M | 86.20M | |
Interest Expense
| 129.00M | 137.20M | 195.30M | 318.20M | |
Interest Expense Growth
| -1.60% | +6.36% | +42.35% | +62.93% | |
Gross Interest Expense
| 129.40M | 138.10M | 197.40M | 323.70M | |
Interest Capitalized
| 400.00K | 900.00K | 2.10M | 5.50M | |
Pretax Income
| (763.10M) | (233.00M) | 354.40M | 51.80M | |
Pretax Income Growth
| -289.50% | +69.47% | +252.10% | -85.38% | |
Pretax Margin
| -10.45% | -2.19% | +1.75% | +0.31% | |
Income Tax
| (192.70M) | (62.50M) | 63.90M | 5.10M | |
Income Tax - Current - Domestic
| (160.60M) | (3.10M) | 2.30M | 6.70M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| (32.10M) | (59.40M) | 61.60M | (1.60M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 30.30M | 18.30M | 57.70M | 86.20M | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (570.40M) | (170.50M) | 290.50M | 46.70M | |
Minority Interest Expense
| 37.60M | 33.00M | 33.40M | 26.90M | |
Net Income
| (608.00M) | (203.50M) | 257.10M | 19.80M | |
Net Income Growth
| -299.08% | +66.53% | +226.34% | -92.30% | |
Net Margin Growth
| -8.33% | -1.91% | +1.27% | +0.12% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (608.00M) | (203.50M) | 257.10M | 19.80M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (608.00M) | (203.50M) | 257.10M | 19.80M | |
EPS (Basic)
| -8.261 | -2.7506 | 3.6319 | 0.3027 | |
EPS (Basic) Growth
| -306.13% | +66.70% | +232.04% | -91.67% | |
Basic Shares Outstanding
| 73.60M | 73.98M | 70.79M | 65.41M | |
EPS (Diluted)
| -8.261 | -2.7506 | 3.595 | 0.3001 | |
EPS (Diluted) Growth
| -308.09% | +66.70% | +230.70% | -91.65% | |
Diluted Shares Outstanding
| 73.60M | 73.98M | 71.52M | 65.98M | |
EBITDA
| (185.00M) | 134.90M | 835.20M | 734.60M | |
EBITDA Growth
| -127.10% | +172.92% | +519.13% | -12.05% | |
EBITDA Margin
| -2.53% | +1.27% | +4.13% | +4.34% |
Snapshot
Average Recommendation | HOLD | Average Target Price | 20.357 | |
Number of Ratings | 14 | Current Quarters Estimate | -1.585 | |
FY Report Date | 12 / 2024 | Current Year's Estimate | -4.488 | |
Last Quarter’s Earnings | -1.45 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 2.98 | Next Fiscal Year Estimate | -2.156 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 14 | 12 | 14 | 14 |
Mean Estimate | -1.59 | -1.01 | -4.49 | -2.16 |
High Estimates | -0.75 | -0.17 | -3.88 | 0.68 |
Low Estimate | -2.25 | -1.79 | -5.19 | -4.12 |
Coefficient of Variance | -26.15 | -50.72 | -8.73 | -68.95 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 1 | 1 | 1 |
OVERWEIGHT | 1 | 1 | 1 |
HOLD | 7 | 7 | 4 |
UNDERWEIGHT | 1 | 1 | 0 |
SELL | 4 | 4 | 6 |
MEAN | Hold | Hold | Underweight |
SEC Filings for Delek Us Holdings Inc. - DK
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Delek Us Holdings Inc. - DK
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Sep 13, 2024 | Avigal Soreq President & CEO; Director | 184,501 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.35 per share | 3,570,094.35 |
Sep 13, 2024 | Robert Wright SVP & Deputy CFO | 28,296 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.35 per share | 547,527.60 |
Sep 13, 2024 | Robert Wright SVP & Deputy CFO | 18,526 | Open market or private purchase of non-derivative security Non-derivative transaction at $23.73 per share | 439,621.98 |
Sep 13, 2024 | Reuven Spiegel CFO | 46,930 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.35 per share | 908,095.50 |
Sep 13, 2024 | Robert Wright SVP & Deputy CFO | 28,430 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $26.5 per share | 753,395.00 |
Sep 13, 2024 | Denise Clark McWatters EVP, Gen Counsel & Corp Sec | 41,668 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.35 per share | 806,275.80 |
Aug 23, 2024 | Richard J. Marcogliese Director | 43,163 | Open market or private purchase of non-derivative security Non-derivative transaction at $20.52 per share | 885,704.76 |
Aug 23, 2024 | Richard J. Marcogliese Director | 43,393 | Open market or private purchase of non-derivative security Non-derivative transaction at $20.43 per share | 886,518.99 |
Jun 13, 2024 | Reuven Spiegel CFO | 50,456 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $24.14 per share | 1,218,007.84 |
Jun 13, 2024 | Gary M. Sullivan Director | 48,362 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $24.88 per share | 1,203,246.56 |
Jun 13, 2024 | Vicky Sutil Director | 30,603 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $24.88 per share | 761,402.64 |
Jun 13, 2024 | Christine Benson Schwartzstein Director | 7,783 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $24.88 per share | 193,641.04 |
Jun 13, 2024 | Laurie Z. Tolson Director | 15,753 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $24.14 per share | 380,277.42 |
Jun 13, 2024 | Laurie Z. Tolson Director | 16,357 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $24.88 per share | 406,962.16 |
Jun 13, 2024 | Shlomo Zohar Director | 40,967 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $24.88 per share | 1,019,258.96 |
Jun 13, 2024 | Leonardo Eleutério Moreno Director | 15,604 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $24.88 per share | 388,227.52 |
Jun 13, 2024 | William J. Finnerty Director | 44,367 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $24.88 per share | 1,103,850.96 |
Jun 12, 2024 | Joseph Israel EVP, Operations | 38,141 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $25.28 per share | 964,204.48 |
Mar 13, 2024 | Reuven Spiegel CFO | 54,732 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $26.5 per share | 1,450,398.00 |
Mar 13, 2024 | Reuven Spiegel CFO | 55,161 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $26.01 per share | 1,434,737.61 |